| Literature DB >> 24799338 |
Piotr Obuch-Woszczatyński1, Dominika Lachowicz1, Anna Schneider2, Anna Mól2, Jolanta Pawłowska3, Ewa Ożdżeńska-Milke4, Piotr Pruszczyk4, Dorota Wultańska1, Grażyna Młynarczyk1, Celine Harmanus5, Ed J Kuijper5, Alex van Belkum6, Hanna Pituch7.
Abstract
Since 2003, a rising incidence of Clostridium difficile infection (CDI) in North America and Europe has coincided with outbreaks of C. difficile PCR ribotype 027. This ribotype was not observed in Poland until 2008. In the period 2008-2010, outbreaks of antibiotic-associated diarrhoea occurred in three different hospitals in Poland. Of 30 C. difficile isolates available for microbiological characterisation, 17 (56%) were positive for binary toxin genes and belonged to PCR ribotype 027 (n = 7) and its closely related PCR ribotype 176 (n = 10). All 17 binary toxin-positive C. difficile strains demonstrated high-level resistance to fluoroquinolones (minimum inhibitory concentration (MIC) ≥ 32 mg/L), including ciprofloxacin, gatifloxacin, and moxifloxacin, as well as erythromycin and clindamycin (MIC ≥ 256 mg/L for both). Of 14 patients from whom clinical information was available, 50% had a severe form of CDI, defined by fever (>38.5 °C), decreased kidney function, and high leucocyte count. We conclude that outbreaks of CDI associated with hypervirulent strains belonging to PCR ribotypes 027 and 176 occurred in hospitals in Poland. Further studies evaluating the clinical impact of type 176 are urgently needed.Entities:
Keywords: Clostridium difficile infection; Outbreak; PCR ribotype 027; PCR ribotype 176
Mesh:
Substances:
Year: 2014 PMID: 24799338 DOI: 10.1016/j.anaerobe.2014.04.007
Source DB: PubMed Journal: Anaerobe ISSN: 1075-9964 Impact factor: 3.331